Search Results 691-700 of 15910 for pharmacogenetics
Assessment of long-term safety and efficacy of oral lacosamide (LCM) as an adjunctive therapy for uncontrolled primary generalized tonic-clonic (PGTC) seizures ...
About this study. The purpose of this study is to assess age-dependent increases in Von Willebrand Factor (VWF) levels in patients with Type 1 Von ...
The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...
August John, Ph.D. student at Mayo Clinic Graduate School of Biomedical Sciences, shares research on developing a new method to optimize cancer drugs.
The purpose of this study is to evaluate the long-term safety and effectiveness of Lonapegsomatropin administered once-weekly. Participation eligibility.
Learn how genetic testing can help customize your cancer treatment plan. Precision medicine is improving breast cancer diagnosis, treatment and prevention.
PHOENIX — A drug combination designed to enhance the immune system's ability to zero in and attack cancer cells has shown a pronounced therapeutic effect ...
The purpose of this study is to determine the effect of endogenous glucagon-like peptide-1 on active intestinal glucose transport and on intestinal permeability ...
The purpose of this study is to report the prevalence and severity of DR regarding pre-operative fertility preservation choices among TGGNB men/persons ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.